Japan vs Republic of Korea: Number of isolates tested for ceftriaxone
Japan
134
in 2020
Republic of Korea
115
in 2018
Japan rank
22nd
Republic of Korea rank
25th
Number of isolates tested for ceftriaxone over time
- Japan
- Republic of Korea
How they compare
Japan currently reports 134 against 115 in Republic of Korea, a difference of 19.
That makes Japan's figure about 1.2 times Republic of Korea's.
Across all 9 years both countries report, Japan has been ahead every year.
Japan ranks 22nd and Republic of Korea ranks 25th of 52 countries.
Japan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Japan | Republic of Korea | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 403 | 82 | 321 | Japan |
| 2010s | 417.38 | 66.62 | 350.75 | Japan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher number of isolates tested for ceftriaxone, Japan or Republic of Korea?
- Japan, at 134 against 115 in Republic of Korea as of 2020.
- What is the difference in number of isolates tested for ceftriaxone between Japan and Republic of Korea?
- 19, with Japan ahead.
- How many years of comparable data are there for Japan and Republic of Korea?
- 9 years are reported by both, from 2009 to 2018.
- How do Japan and Republic of Korea rank globally for number of isolates tested for ceftriaxone?
- Japan ranks 22nd and Republic of Korea ranks 25th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Number of isolates tested for ceftriaxone. Statizoid refreshes it automatically from the source and publishes the full history for both places.